Wird geladen...

Next-generation sequencing in hematologic malignancies: what will be the dividends?

The application of high-throughput, massively parallel sequencing technologies to hematologic malignancies over the past several years has provided novel insights into disease initiation, progression, and response to therapy. Here, we describe how these new DNA sequencing technologies have been appl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Merker, Jason D., Valouev, Anton, Gotlib, Jason
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2012
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3627325/
https://ncbi.nlm.nih.gov/pubmed/23606936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620712458948
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!